We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVLO
12276
CALL
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$44K ﹤0.01%
645
-5,080
-89% -$423K
SGTX
12277
CALL
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$44K ﹤0.01%
2,308
-7
-0.3% -$156
SRGA
12278
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$44K ﹤0.01%
4,801
-66
-1% -$1K
ADN
12279
CALL
DELISTED
Advent Technologies
ADN
$43K ﹤0.01%
623
-987
-61% -$112K
CRVS icon
12280
PUT
Corvus Pharmaceuticals
CRVS
$1.19B
$43K ﹤0.01%
26,500
-54,900
-67% -$101K
DPRO
12281
CALL
Draganfly
DPRO
$166M
$43K ﹤0.01%
716
-984
-58% -$36.3K
FTK icon
12282
Flotek Industries
FTK
$867M
$43K ﹤0.01%
5,739
-5,723
-50% -$40.8K
LFT
12283
Lument Finance Trust
LFT
$38.9M
$43K ﹤0.01%
+15,715
New +$49.6K
LSTA icon
12284
CALL
Lisata Therapeutics
LSTA
$15.2M
$43K ﹤0.01%
3,940
+2,220
+129% +$25.4K
PAVM icon
12285
CALL
PAVmed
PAVM
$39.3M
$43K ﹤0.01%
72
-66
-48% -$49K
PTN
12286
Palatin Technologies
PTN
$18.6M
$43K ﹤0.01%
75
+28
+60% +$14.6K
SONM icon
12287
DNA X Inc
SONM
$5.15M
$43K ﹤0.01%
277
+113
+69% +$15.3K
KA
12288
DELISTED
Kineta, Inc. Common Stock
KA
$43K ﹤0.01%
4,061
+1,750
+76% +$21.5K
NEPT
12289
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$43K ﹤0.01%
139
-222
-61% -$101K
IVC
12290
DELISTED
Invacare Corporation
IVC
$43K ﹤0.01%
30,661
-40,303
-57% -$86.2K
AUTO
12291
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$43K ﹤0.01%
18,779
-24,008
-56% -$64.2K
SRXH
12292
SRX Global
SRXH
$34.7M
$42K ﹤0.01%
8
-7
-47% -$38.2K
CRVS icon
12293
CALL
Corvus Pharmaceuticals
CRVS
$1.19B
$42K ﹤0.01%
25,500
-38,800
-60% -$71K
DZZ icon
12294
DB Gold Double Short ETN due Feb 15 2038
DZZ
$3.04M
$42K ﹤0.01%
17,686
+6,983
+65% +$17.8K
FLUX icon
12295
PUT
Flux Power
FLUX
$13.5M
$42K ﹤0.01%
15,600
-14,500
-48% -$44.1K
FTFT icon
12296
Future FinTech Group
FTFT
$17.9M
$42K ﹤0.01%
69
-158
-70% -$107K
NSPR icon
12297
InspireMD
NSPR
$39.8M
$42K ﹤0.01%
13,103
+2,292
+21% +$6.35K
TK icon
12298
Teekay
TK
$1.14B
$42K ﹤0.01%
13,294
-28,720
-68% -$93K
YRD
12299
Yiren Digital
YRD
$91.9M
$42K ﹤0.01%
16,515
-336
-2% -$881
IRD
12300
CALL
Opus Genetics
IRD
$307M
$42K ﹤0.01%
13,000
-80,500
-86% -$276K

Similar funds

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.